DCM Shriram announced that Dr. Paresh Verma, Executive Director & Research Director - Bioseed Research Business of the Company, will retire from the services of the Company with effect from closing of business hours of 31 October 2025, after leading this business for over 23 years. Consequently, Dr. Verma will also cease to be Senior Management Personnel (SMP) with effect from the said date. Powered by Capital Market - Live News

DCM Shriram announced that the Board of Directors of the Company at its meeting held on 28 October 2025, inter alia, have recommended the interim dividend of Rs 3.6 per equity Share (i.e. 180%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of DCM Shriram rose 151.18% to Rs 158.04 crore in the quarter ended September 2025 as against Rs 62.92 crore during the previous quarter ended September 2024. Sales rose 10.68% to Rs 3255.11 crore in the quarter ended September 2025 as against Rs 2940.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3255.112940.95 11 OPM %9.506.16 - PBDT364.86196.64 86 PBT245.8695.77 157 NP158.0462.92 151 Powered by Capital Market - Live News

DCM Shriram will hold a meeting of the Board of Directors of the Company on 28 October 2025.Powered by Capital Market - Live News

DCM Shriram has received affirmation in credit rating for commercial paper aggregating Rs 700 crore at CRISIL A1+. Powered by Capital Market - Live News